| 2851 |
LOSECTIL 20 |
OMEPRAZOLE USP 20 MG |
CAPSULE |
ALU-ALU STRIP |
TREATMENT OF OESOPHAGEAL REFLUX DISEASE, TREATMENT OF DUODENAL AND BENIGN GASTRIC ULCERS INCLUDING THOSE COMPLICATIONG NSAID THERAPY, TREATMENT OF ASSOCIATED DYSPEPTIC SYMPTOMS, PROPHYLAXIS OF ACID ASPIRATION. |
NULL |
VIMPEX (LAO) CO.,LTD |
ESKAYEF PHARMACEUTICALS LIMITED |
BANGLADESH |
CERTIFICATE RELEASED |
06 I 4763/19 |
07-JUL-2025 |
06-JUL-2030 |
View |
| 2852 |
LOSECTIL 40 |
OMEPRAZOLE USP 40 MG |
CAPSULE |
ALU-ALU STRIP |
TREATMENT OF OESOPHAGEAL REFLUX DISEASE, TREATMENT OF DUODENAL AND BENIGN GASTRIC ULCERS INCLUDING THOSE COMPLICATIONG NSAID THERAPY, TREATMENT OF ASSOCIATED DYSPEPTIC SYMPTOMS, PROPHYLAXIS OF ACID ASPIRATION. |
NULL |
VIMPEX (LAO) CO.,LTD |
ESKAYEF PHARMACEUTICALS LIMITED |
BANGLADESH |
CERTIFICATE RELEASED |
06 I 4762/19 |
07-JUL-2025 |
06-JUL-2030 |
View |
| 2853 |
MAXRON 0.4 MG |
TAMSULOSIN HYDROCHLORIDE EQ.TO TAMSULOSIN 0.4 MG |
CAPSULE |
ALU-ALU BLISTERPACK |
TREATMENT OF MODERATE TO SEVERE SYMPTOMS OF BENIGN PROSTATIC HYPERPLASIA(BPH), REDUCTION IN THE RISK OF ACUTE URINARY RETENTION AND SURGERY IN PATIENTS WITH MODERATE TO SEVERE SYMPTOM OF BPH. |
NULL |
VIMPEX (LAO) CO.,LTD |
WILSHIRE LABORATORIES(PVT) LTD |
PAKISTAN |
CERTIFICATE RELEASED |
11 I 4623/18 |
26-SEP-2022 |
25-SEP-2025 |
View |
| 2854 |
METFOKANT 500 |
METFORMIN HYDROCHLORIDE 500 MG |
TABLET |
ALU-PVC BLISTER |
NON-INSULIN DEPENDENT DIABETES WHEN DIET HAS FAILED AND ESPECIAL IF THE PATIENT IS OVERWEIGHT. |
NULL |
VIMPEX (LAO) CO.,LTD |
S KANT HEALTHCARE LTD |
INDIA |
CERTIFICATE RELEASED |
01 I 5689/24 |
06-FEB-2024 |
05-FEB-2027 |
View |
| 2855 |
METFOKANT 850 |
METFORMIN HYDROCHLORIDE 850 MG |
TABLET |
ALU-PVC BLISTER |
NON-INSULIN DEPENDENT DIABETES WHEN DIET HAS FAILED AND ESPECIAL IF THE PATIENT IS OVERWEIGHT. |
NULL |
VIMPEX (LAO) CO.,LTD |
S KANT HEALTHCARE LTD |
INDIA |
CERTIFICATE RELEASED |
01 I 5690/24 |
06-FEB-2024 |
05-FEB-2027 |
View |
| 2856 |
MOSI EYE DROPS |
MOXIFLOXACIN HYDROCHLORIDOE EQ.TO MOXIFLOXACIN 5 MG/ ML |
DROPS |
VIAL |
TOPICAL TREATMENT OF PURULENT BACTERIAL CONJUNCTIVIS CAUSED BY MOXIFLOXACIN SUSCEPTIBLE STRAINS. |
NULL |
VIMPEX (LAO) CO.,LTD |
FDC LIMITED |
INDIA |
CERTIFICATE RELEASED |
08 I 5602/23 |
05-SEP-2023 |
04-SEP-2026 |
View |
| 2857 |
MYCODERM-C |
CLOTRIMAZOLE BP 1 % W/W |
POWDER |
HDPE CONTAINER |
AS AN ADJUNCT TO TREATMENT WITH CLOTRIMAZOLE CREAM, SOLUTION OR DERMATOLOGICAL SPRAY AND AS A PROPHYLACTIC AGAINST REINFECTION, PARTICULARLY INFECTION INVOLVING SKIN FOLDS AND WHERE PERSPIRATION IS A PROBLEM. |
NULL |
VIMPEX (LAO) CO.,LTD |
FDC LIMITED |
INDIA |
CERTIFICATE RELEASED |
06 I 5775/24 |
27-Jun-2024 |
26-Jun-2027 |
View |
| 2858 |
MYOSPAZ |
CHLORZOXAZONE USP 250 MG, PARACETAMOL BP 500 MG |
TABLET |
ALU-PVC STRIP |
FOR THE RELIEF OF PAIN AND MUSCLE SPASM ASSOCIATED WITH INFLAMMATORY AND DEGENERATIVE PROCESSES, FIBROSITIS, MUOSITIS, BURSITIS, TENOSYNOVITIS, TORTICOLLIS. OSTEOARTHRITIS, TRAUMA, INTERVERTEBRAL DISC SYNDROME, LUMBAGO, SACROILIAC PAIN, MUSCULAR AND TENDINOUS SPRAINS, CONTUSIONS, POST OPERATIVE MYALGIA, POST TOOTH EXTRACTION |
NULL |
VIMPEX (LAO) CO.,LTD |
WIN-MEDICARE PRIVATE LIMITED |
INDIA |
CERTIFICATE RELEASED |
12 I 5022/20 |
08-JAN-2024 |
07-JAN-2027 |
View |
| 2859 |
NAPA TABLET |
PARACETAMOL 500 MG |
TABLET |
ALU-PVC STRIP |
RELIEF OF MILD TO MODERATE PAIN AND FEBRILE CONDITIONS E.G. HEADACHE, TOOTHACHE, COLDS, INFLUENZA, RHEUMATIC PAIN AND DYSMENORRHOEA |
NULL |
VIMPEX (LAO) CO.,LTD |
BEXIMCO PHARMACEUTICALS LIMITED |
BANGLADESH |
CERTIFICATE RELEASED |
10 I 5637/23 |
17-OCT-2023 |
16-OCT-2026 |
View |
| 2860 |
NEOGLIP 50/500 MG TABLET |
SITAGLIPTIN (AS PHOSPHATE) 50 MG, METFORMIN HCL 500 MG |
FILM COATED TABLET |
ALU-ALU BLISTER |
AS AN ADJUNCT TO DIET AND EXCERCISE TO IMPROVE GLYCEMIC CONTROL IN PATIENTS INADEQUATELY CONTROLLED ON THEIR MAXIMAL TOLERATED DOSE OF METFORMIN ALONE OR THOSE ALREADY BEING TREATED WITH COMBINATION OF SITAGLIPTIN AND METFORMIN |
NULL |
VIMPEX (LAO) CO.,LTD |
ATCO LABORATORIES LIMITED |
PAKISTAN |
CERTIFICATE RELEASED |
12 I 5357/22 |
30-DEC-2022 |
29-DEC-2025 |
View |
